Ge Junbo: Keep a bit naive, that is the driving force for innovation

Another great doctor of common people was included in the heavy list of Shanghai Science and Technology Meritorious Award yesterday.

Ge Junbo has long been committed to promoting technological innovation and achievement transformation in the diagnosis and treatment of major cardiovascular diseases in my country, and has set many "world firsts" and "firsts in China" in the field of heart disease: he pioneered the "reverse guide wire technology" in the world and overcomes the complexity.

Cure diseases that others can't cure

Half of the "moon" starts the journey of conquering "heart disease"

Ge Junbo's left arm has always been a little bend, which is the sequelae of his broken bones when he was young and failed to get timely and proper treatment.

Since being admitted to Qingdao Medical College in Shandong Province in 1979, Ge Junbo has worked hard all the way, from Shandong Medical University to Shanghai Medical University, and then to the School of Medicine of the University of Mainz in Germany, and has made numerous academic achievements.

A clear diagnosis is critical to saving the lives of patients.

In 1993, Ge Junbo tried to see the inside of the blood vessel wall with an ultrasound probe.

Along this vein, Ge Junbo also discovered the "fingertip phenomenon" in the Doppler blood flow spectrum characteristics of the myocardial bridge, thus revising the traditional medication method.

In order to "cure diseases that others cannot cure", Ge Junbo challenged the "forbidden zone" of cardiovascular disease again and again.

Chronic Total Coronary Occlusion (CTO) is the "last fortress" to be overcome for interventional treatment of complex coronary artery disease.

There are as many as tens of millions of patients with mitral regurgitation in my country, and about 30% of them cannot tolerate traditional thoracotomy due to old age and frailty.

In addition, Ge Junbo also advocated the establishment of "1120 Chinese Myocardial Infarction Treatment Day".

A chivalrous heart

Allow patients to spend less money and use better medical equipment

In 1999, at the time when the German career was developing well, Ge Junbo resolutely decided to return to Shanghai to work hard for the development of the motherland's health care.

At that time, domestic coronary interventional surgery was developing rapidly, and the amount of surgery was increasing at an annual rate of 20% to 30%.

People familiar with Ge Junbo know that he likes martial arts novels, especially Xiao Feng written by Jin Yong, "because he has a chivalrous heart.

During the treatment, Ge Junbo discovered that the widely used drug stents were coated with non-degradable materials.

I can’t remember how many setbacks and failures he has experienced.
In the end, Ge Junbo’s team developed a new type of biodegradable coated drug stent with my country’s independent intellectual property rights in 2005, and it was widely used in clinical practice-this type of stent greatly reduced the number of stents.
The incidence of internal thrombosis has also dropped from 40,000 yuan to more than 10,000 yuan.

"This not only means that the annual savings for patients and health care costs the country billions of dollars, but also shorten the course of antiplatelet therapy to reduce the patient's risk of bleeding.
" Junbo Ge's first doctoral student, Zhongshan Hospital, the incumbent vice president , heart Professor Qian Juying, the deputy director of internal medicine, introduced that the stent currently accounts for 22% of the domestic market and is exported to more than ten countries or regions including Russia, Singapore, and India.

After 15 years of exploration, Ge Junbo’s team successfully developed the first domestically biodegradable stent in 2013, which can be completely degraded and absorbed after being implanted in the body for three to five years.
In 2020, the stent will be successfully listed on the market through national approval, which marks the completion of the "fourth revolution" of coronary interventional therapy in my country.

Keep it naive

Take the lead in the doctor's innovation club and drive the progress of the entire industry

"Retain a bit of naivety, that is the driving force for innovation.
" Ge Junbo said that medicine is a rigorous science, but it does not mean that all theories and technologies are immutable.
They maintain a naive attitude towards traditional views and are not bound by traditional theories.
, Constantly questioning, there is the motivation for innovation.

Moreover, he believes that one person cannot perform all the operations, and only improving the overall quality and skills of the doctors is the feasible way to ultimately benefit the patients.
Therefore, Ge Junbo continues to build a doctor's innovation platform to activate the innovative potential of doctors, especially young doctors, and drive and promote the innovation and progress of the entire industry.

In overcoming medical problems, Ge Junbo always put forward a series of basic research questions and medical device research and development topics.
"It is necessary to solve technical problems in the medical field through collaborative innovation.
" Under his leadership, the China Cardiovascular Doctor Innovation Club was established in 2015, attracting a large number of young and middle-aged doctors with innovative consciousness and vitality to participate.

In 2020, Ge Junbo took the lead in establishing the "Chief Innovation Officer (CIO)" in the Department of Cardiology, Zhongshan Hospital.
The CIO solicits the problems and difficulties encountered by each medical staff in their work, and then seeks solutions to assist in applying for patents to promote transformation.
He hopes that innovation will bring greater development potential to medicine and relieve patients of more illnesses.